A new study from the University of California, Davis, has uncovered how cells in the pancreas work together to stop blood sugar from dropping too low. This discovery could lead to better treatments ...
In a medical first, researchers report that they have implanted CRISPR-edited pancreas cells into a person with type 1 diabetes. The cells pumped out sugar-regulating insulin for months — without the ...
People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life after diagnosis. The autoimmune disease destroys the cells that produce the hormone, ...
Fresh hope for type 1 diabetes as daily pill that slows onset confirms promise at two-year follow-up
In 2023, the groundbreaking Australian BANDIT (Baricitinib in New Onset Type 1 Diabetes) trial reported that a daily pill of baricitinib, commonly prescribed for rheumatoid arthritis and alopecia, ...
BERLIN, Aug 1 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab will invest 1.3 billion euros ($1.40 billion) in a new insulin production facility at its existing site in Frankfurt, where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback